Replies to post #69 on Dusa Pharma (Dusa)

[surf1944]

7:53AM On The Wires (WIRES) DUSA Pharmaceuticals (DUSA) announced that patient enrollment is complete in its Phase 2 clinical trial studying the broad area application with 1, 2 and 3-hour drug incubation for the treatment of actinic keratoses of the face or scalp. Co also completed enrollment in its pilot Phase 2 clinical trial studying the safety and efficacy of treating AKs on the upper extremities